WHY IT MATTERS: Veterans currently using cannabis or pursuing psychedelic therapy outside the VA system risk losing continuity of care, benefits eligibility concerns, and lack of clinical supervision that a formal federal program would provide. CLINICAL OVERVIEW: Veterans organizations are pressing Congress to broaden access to both cannabis and psychedelic-assisted therapies through the VA system as a response to the persistently high suicide rate among veterans. The push reflects growing clinical evidence that current pharmacological and psychological treatment options are failing a significant portion of this population, particularly those with treatment-resistant PTSD and co-occurring substance use disorders.
In the Mix: 9 More Articles — March 05, 2026
9 cannabis articles reviewed and scored below the CED clinical relevance threshold in the March 05, 2026 feed update. Organized by topic with summaries and source links.
Study Links Rising Cannabis Use to Poor Mental Health – U.S. News & World Report
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. Mental HealthResearchAgingSafety Why This Matters Clinicians need to be aware that cannabis use in older...
Ricketts addresses Congress leaving Nebraska off list protecting state medical cannabis laws
✦ New CED Clinical Relevance #45 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyMedical Cannabis Why This Matters Clinicians in Nebraska need to understand that their state’s continued...
Study Links Rising Cannabis Use to Poor Mental Health – HealthDay
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. Mental HealthResearchAnxietySafety Why This Matters Clinicians should understand this association when screening patients for cannabis...
endocannabinoid system clinical research in athlete mental health
Clinical Takeaway Retired professional athletes from high contact team sports such as football, rugby, and ice hockey show elevated rates of depression, anxiety, and cognitive concerns compared to the general population. Career-ending...
Cannabinoid Formulations for Anxiety and Tourette Syndrome
Clinical Takeaway Cannabinoid formulations, particularly CBD-containing products, show measurable reductions in anxiety symptoms across multiple study designs, though effect sizes and optimal dosing vary by condition and formulation. Evidence for Tourette syndrome...
Endocannabinoid System & Teen Mental Health: Clinical Evidence
Clinical Takeaway Adolescents with higher levels of depression and anxiety symptoms were more likely to initiate and use cannabis more frequently over the following 18 months, supporting the idea that young people...
Pipeline Progress Drives Investor Focus at Agentix – Ad-hoc-news.de
✦ New CED Clinical Relevance #45 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchNeurologyPainAnxiety Why This Matters As Agentix advances endocannabinoid-targeting drug candidates through clinical development, clinicians should...
Endocannabinoid System Research: Cannabis & Teen Mental Health
Clinical Takeaway Adolescents with higher levels of depression and anxiety symptoms were more likely to initiate and use cannabis more frequently over the following 18 months. This longitudinal evidence supports the self-medication...